Hemostemix Executes Strategic Alliance with Hemostemix Asia for Expansion of Phase-2 Clinical Trial to Taiwan
September 14, 2015 08:30 ET
|
Hemostemix Inc.
TORONTO, ONTARIO--(Marketwired - Sept. 14, 2015) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM), a clinical-stage autologous cell-therapy company, announced today...
Hemostemix Holds First Meeting of Data Safety Monitoring Board (DSMB)
August 20, 2015 08:30 ET
|
Hemostemix Inc.
TORONTO, ONTARIO--(Marketwired - Aug. 20, 2015) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM), a clinical-stage autologous cell-therapy company that has treated 15...
Hemostemix Receives FDA Clearance for Phase-2 Clinical Trial of Lead Product ACP-01 in the United States
August 10, 2015 08:30 ET
|
Hemostemix Inc.
TORONTO, ONTARIO--(Marketwired - Aug. 10, 2015) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM), a clinical-stage autologous cell-therapy company, announced that the...
Hemostemix Enrolls 20th Participant and Treats 15th in International Clinical Trial for Critical Limb Ischemia
July 27, 2015 08:30 ET
|
Hemostemix Inc.
CALGARY, ALBERTA--(Marketwired - July 27, 2015) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM), a clinical-stage autologous cell-therapy company, announced another...
Hemostemix Forms Strategic Alliance in Asia
July 23, 2015 08:30 ET
|
Hemostemix Inc.
TORONTO, ONTARIO--(Marketwired - July 23, 2015) - Hemostemix, Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM), a clinical-stage autologous cell-therapy company, announced today...
Hemostemix Posts Corporate Presentation on Company Website
July 07, 2015 08:30 ET
|
Hemostemix Inc.
CALGARY, ALBERTA--(Marketwired - July 7, 2015) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM), a clinical-stage autologous cell-therapy company, announced today that...